Literature DB >> 19918039

A cluster within the continuum of biopsychosocial distress can be labeled "fibromyalgia syndrome"--evidence from a representative German population survey.

Winfried Häuser1, Gabriele Schmutzer, Elmar Brähler, Heide Glaesmer.   

Abstract

OBJECTIVE: We tested the hypothesis that "fibromyalgia syndrome" is a biopsychosocial continuum disorder.
METHODS: A cross-sectional survey of a representative sample of the German general population with persons >or= 14 years of age was conducted based on face-to-face contacts. Physical distress was measured by the regional pain scale (RPS) and the Patient Health Questionnaire 15 (PHQ-15), psychological distress by the PHQ-9, and social distress by the Oslo Social Support Scale. Health-related quality of life (HRQOL) was measured by the 12-item form of the Medical Outcome Study Short Form Health Survey. A k-means clustering procedure with 2-8 clusters preset was used to classify the scores of the RPS, PHQ-9, and PHQ-15. The number of clusters retained was based on the stability and interpretability of the clusters. The cluster analysis was first performed with a randomly selected half of the sample and then cross-validated on the second half of the total sample.
RESULTS: A 4-cluster solution produced the most stable and meaningful results. Cluster 1 was very low on all symptom scores. Cluster 2 was low on pain sites, somatic symptoms, and depression. Cluster 3 was high on pain scores, moderate on somatic symptoms, and low on depression. Cluster 4 was high on all symptom scores. The centroids of cluster 4 met the survey criteria of fibromyalgia syndrome. Cluster 4 reported a lower HRQOL and less social support compared to the other 3 groups.
CONCLUSION: A cluster within the continuum of biopsychosocial distress can be labeled fibromyalgia syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19918039     DOI: 10.3899/jrheum.090579

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients.

Authors:  Hyein Kim; Jing Cui; Michelle Frits; Christine Iannaccone; Jonathan Coblyn; Nancy A Shadick; Michael E Weinblatt; Yvonne C Lee
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

Review 2.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

3.  Multiple somatic symptoms predict impaired health status in functional somatic syndromes.

Authors:  F H Creed; B Tomenson; C Chew-Graham; G J Macfarlane; I Davies; J Jackson; A Littlewood; J McBeth
Journal:  Int J Behav Med       Date:  2013-06

4.  [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].

Authors:  W Eich; W Häuser; B Arnold; W Jäckel; M Offenbächer; F Petzke; M Schiltenwolf; M Settan; C Sommer; T Tölle; N Uçeyler; P Henningsen
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

5.  Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population.

Authors:  Jens C Türp; Gabriele Schmutzer; Elmar Brähler; Winfried Häuser
Journal:  Clin Oral Investig       Date:  2015-11-27       Impact factor: 3.573

Review 6.  Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis.

Authors:  Sean D Boyden; Imtiyaz N Hossain; Alyssa Wohlfahrt; Yvonne C Lee
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

7.  Profiles in fibromyalgia: algometry, auditory evoked potentials and clinical characterization of different subtypes.

Authors:  Yolanda Triñanes; Alberto González-Villar; Claudio Gómez-Perretta; María T Carrillo-de-la-Peña
Journal:  Rheumatol Int       Date:  2014-04-11       Impact factor: 2.631

Review 8.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

9.  Subgrouping patients with fibromyalgia according to the results of the Fibromyalgia Impact Questionnaire: a replication study.

Authors:  Elena P Calandre; Jocelyne Garcia-Carrillo; Juan M Garcia-Leiva; Fernando Rico-Villademoros; Rocío Molina-Barea; Carmen M Rodriguez-Lopez
Journal:  Rheumatol Int       Date:  2010-05-20       Impact factor: 2.631

10.  In-Patient Treatment of Fibromyalgia: A Controlled Nonrandomized Comparison of Conventional Medicine versus Integrative Medicine including Fasting Therapy.

Authors:  Andreas Michalsen; Chenying Li; Katharina Kaiser; Rainer Lüdtke; Larissa Meier; Rainer Stange; Christian Kessler
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.